The Valley Desk

ReviewJAMA oncologyPublished

PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
JAMA oncology
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Immunotherapy; Randomized Controlled Trials as Topic; B7-H1 Antigen; Progression-Free Survival; Immune Checkpoint Inhibitors
PubMed ID
42240993
Added to directory
Source checked

Report a correction or request removal